Telescope Innovations Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TELIF research report →
About the company
Telescope Innovations Corp. is a chemical technology firm dedicated to creating synthetic methods for producing pharmaceutical compounds. These compounds are specifically developed for use in treating mental health conditions.
- CEO
- Henry Dubina
- IPO
- 2022
- Employees
- 5
- HQ
- Vancouver, BC, CA
Price Chart
- Market Cap
- $27.78M
- P/E
- -12.57
- P/S
- 5.31
- P/B
- 16.92
- EV/EBITDA
- -10.09
- Div Yield
- 0.00%
- Gross Margin
- 2.22%
- Op Margin
- -70.61%
- Net Margin
- -56.03%
- ROE
- -101.95%
- ROIC
- -84.44%
- Revenue
- $4.78M · 0.00%
- Net Income
- $-1,562,812 · 0.00%
- EPS
- $-0.03 · 0.00%
- Op Income
- $-1,348,172
- FCF YoY
- 0.00%
- 52W High
- $0.77
- 52W Low
- $0.20
- 50D MA
- $0.51
- 200D MA
- $0.33
- Beta
- 1.35
- Avg Volume
- 247.99K
Get TickerSpark's AI analysis on TELIF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our TELIF coverage
Recent articles, reports, and earnings notes.
No research on TELIF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TELIF report →Similar companies
Peers in the same neighborhood.